Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity
about
Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosisAmyloidogenic propensity of a natural variant of human apolipoprotein A-I: stability and interaction with ligandsStructural and Functional Analysis of the ApolipoproteinA-I A164S VariantInsight into the Protein Composition of Immunoglobulin Light Chain Deposits of Eyelid, Orbital and Conjunctival Amyloidosis.Binding of human apoA-I[K107del] variant to TG-rich particles: implications for mechanisms underlying hypertriglyceridemia.Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?Dual role of an N-terminal amyloidogenic mutation in apolipoprotein A-I: destabilization of helix bundle and enhancement of fibril formation.Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural InsightsCharacterization of a human apolipoprotein a-I construct expressed in a bacterial system.Effects of the Iowa and Milano mutations on apolipoprotein A-I structure and dynamics determined by hydrogen exchange and mass spectrometry.Renal ApoA-1 amyloidosis with Glu34Lys mutation and intra-amyloid lipid accumulation.Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs.Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.Epigallocatechin-3-gallate remodels apolipoprotein A-I amyloid fibrils into soluble oligomers in the presence of heparin
P2860
Q28116206-A3605BED-A0C3-494D-9CAD-B3CA5A2B49ECQ28547085-B204BB3F-AAEE-4FF8-A8C4-54DC29A73B8AQ28551157-64A1136D-63CD-45E8-80E9-5A69B9D19474Q35820992-C0848413-4E84-4C0E-A3AB-9B12B3FA42DDQ36197671-4C6CA526-71DA-4AD3-B606-D24ED369E2CCQ36553540-861FE739-9E17-4F9B-A182-065E00394B0FQ36562153-C820A8F7-E168-4C84-8EB5-43CD625A62A3Q38543425-826D18E8-66CF-44AD-A810-F3100E63A865Q39551253-EDB60592-F884-4DDD-B1DF-82EB6F097FEFQ41345167-69BF4B2D-9A8C-4C6A-B9E4-2D9DF2F8C018Q43030314-751D5303-5508-4DBF-9F51-2B432379244EQ48247953-C5DFF26D-019C-4464-971A-65169EA474DCQ48962618-EBB06A82-3EFF-4171-B684-B4926DC0BC79Q56422855-C68F809E-A28C-4A70-A7BC-72BD95758ACC
P2860
Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@ast
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@en
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@nl
type
label
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@ast
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@en
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@nl
prefLabel
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@ast
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@en
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@nl
P2093
P2860
P50
P1433
P1476
Human apolipoprotein A-I natur ...... lying amyloidogenic propensity
@en
P2093
Eduardo D Prieto
José Luis Ríos
Nahuel A Ramella
Omar J Rimoldi
Sergio T Ferreira
P2860
P304
P356
10.1371/JOURNAL.PONE.0043755
P407
P577
2012-01-01T00:00:00Z